Dimitrios Mavrelos

Dimitrios Mavrelos

Auto-generated profile, based on publicly available information

Dimitrios Mavrelos

Gynaecology Diagnostic and Outpatient Treatment Unit, University College Hospital, London, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2012 in Human Reproduction
Verified
Journal Article
Open access
PDF file
JNJ. Naftalin
J. Naftalin
WHW. Hoo
W. Hoo
KPK. Pateman
K. Pateman
DMD. Mavrelos
D. Mavrelos
THT. Holland
T. Holland
DJD. Jurkovic
D. Jurkovic
What is the prevalence of adenomyosis in a population of women attending a general gynaecological clinic? Adenomyosis was present in 206 of 985 [20.9%; 95% confidence interval (CI): 18.5–23.6%] women included in the study. Previous studies of occurrence of adenomyosis have been limited to women who underwent hysterectomy, which is likely to overestimate its prevalence compared with the general population of women. There are no large prospective studies on the prevalence of adenomyosis, either in the general population of women or in a general gynaecology clinic setting. This was a prospective observational study set in the general gynaecology clinic of a university teaching hospital between January 2009 and January 2010. There were 985 consecutive women who attended the clinic and underwent structured clinical and transvaginal ultrasound examination in accordance with the study protocol. Morphological features of adenomyosis were systematically recorded with the ultrasound scan to determine its prevalence and factors which may affect its occurrence. Adenomyosis was present in 206/985 [20.9% (95% CI: 18.5–23.6%)] women included in the study. Multivariate analysis showed that the prevalence of adenomyosis was significantly associated with women's age, gravidity and pelvic endometriosis (P< 0.001). In women who subsequently underwent hysterectomy, there was a good level of agreement between the ultrasound and histological diagnosis of adenomyosis [κ = 0.62 (P = 0.001), 95% CI (0.324, 0.912)]. Our estimate of prevalence of adenomyosis is likely to be higher than in the general population as we studied symptomatic women attending a gynaecology clinic. Better estimates of the prevalence of adenomyosis can improve our understanding of the burden of the disease, help to identify women at high risk of developing the condition and facilitate the development of preventative strategies and effective treatment. The authors have no competing interests to declare. The study was not supported by an external grant.

6 April 2016 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
DJDavor Jurkovic
Davor Jurkovic
Jure KnezJure Knez
Jure Knez
AAA. Appiah
A. Appiah
LFL. Farahani
L. Farahani
DMD. Mavrelos
D. Mavrelos
JRJ. A. Ross
J. A. Ross

8 January 2014 in Human Reproduction
Verified
Journal Article
Open access
PDF file
JNJ. Naftalin
J. Naftalin
WHW. Hoo
W. Hoo
KPK. Pateman
K. Pateman
DMD. Mavrelos
D. Mavrelos
XFX. Foo
X. Foo
DJD. Jurkovic
D. Jurkovic
Is the presence of adenomyosis associated with menorrhagia? There was no significant association between adenomyosis and menorrhagia, but there was a significant positive correlation between the severity of adenomyosis on ultrasound and the amount of menstrual loss estimated using pictorial blood loss assessment charts. There is no consensus in the literature with regards to the association between adenomyosis and menorrhagia. Previous studies have been limited to retrospective studies of highly selected populations which mainly included women who underwent hysterectomy. There are no large prospective studies evaluating the association between adenomyosis and menorrhagia, either in the general population of women or in a general gynaecology clinic setting. This was a prospective observational study set in the general gynaecology clinic of a university teaching hospital between January 2009 and January 2010. There were 714 consecutive premenopausal women who attended the clinic and underwent structured clinical and transvaginal ultrasound examination in accordance with the study protocol. Morphological features of adenomyosis were systematically recorded on ultrasound scan. Menorrhagia was determined subjectively by direct questioning and objectively by completion of pictorial blood loss analysis charts. A diagnosis of adenomyosis was made in 157/714 women [22.0% (95% CI: 19.1–25.2%)]. Multivariable analysis showed significant associations between submucous fibroids [OR 5.60 (95% CI: 2.69–11.6)], any fibroids [OR 1.53 (95% CI: 0.91–2.58)] and endometrial polyps [OR 2.81 (95% CI: 1.15–11.7)] and menorrhagia. There were also significant associations between increasing gravidity and BMI and menorrhagia (P < 0.01). There was no significant association between adenomyosis and menorrhagia in the study population, when adenomyosis was assessed as a binary outcome. When severity of adenomyosis was assessed by counting the number of morphological features of adenomyosis in each woman, we found a significant 22% increase in menstrual loss for each additional feature of adenomyosis [OR 1.21 (95% CI: 1.04–1.40)]. A classification of severity of adenomyosis based on the number of ultrasound features present is a novel concept that should be prospectively evaluated in different populations. A better understanding of the relationship between adenomyosis and menorrhagia can help improve counselling of women regarding the significance of this common condition and facilitate future studies assessing the effectiveness of different conservative treatments protocols. The authors have no competing interests. The study was not supported by an external grant.

29 October 2013 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
THTom K Holland
Tom K Holland
ACAlfred Cutner
Alfred Cutner
ESErtan Saridogan
Ertan Saridogan
DMDimitrios Mavrelos
Dimitrios Mavrelos
KPKate Pateman
Kate Pateman
DJDavor Jurkovic
Davor Jurkovic
Endometriosis is a common condition which causes pain and reduced fertility. Treatment can be difficult, especially for severe disease, and an accurate preoperative assessment would greatly help in the managment of these patients. The objective of this study is to assess the accuracy of pre-operative transvaginal ultrasound scanning (TVS) in identifying the specific features of pelvic endometriosis and pelvic adhesions in comparison with laparoscopy.

3 June 2016 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
JNJ. Naftalin
J. Naftalin
WHW. Hoo
W. Hoo
NNN. Nunes
N. Nunes
THT. Holland
T. Holland
DMD. Mavrelos
D. Mavrelos
DJD. Jurkovic
D. Jurkovic

27 July 2010 in Human Reproduction
Verified
Journal Article
Open access
PDF file
DMDimitrios Mavrelos
Dimitrios Mavrelos
JBJara Ben-Nagi
Jara Ben-Nagi
ADAnthony Davies
Anthony Davies
CLChristopher Lee
Christopher Lee
RSRehan Salim
Rehan Salim
DJDavor Jurkovic
Davor Jurkovic
Submucous fibroids are common benign tumours responsible for menorrhagia, subfertility and miscarriage. They can be readily removed by hysteroscopic transcervical resection of myoma (TCRM). To facilitate resection, pre-operative GnRH analogues have been suggested, but the value of this treatment is uncertain. Our aim was to assess the value of pre-operative GnRH analogues for the resection of submucous fibroids. This was a prospective, double-blind, placebo-controlled, randomized trial. Women found to have submucous fibroids on three-dimensional saline infusion sonohysterography (3D SIS) were randomized to receive GnRH or placebo. Following treatment patients underwent TCRM by a single operator blinded to the group allocation. Women were followed up 6 weeks after their operation to ascertain resolution of symptoms. The primary outcome measure of the study was completeness of fibroid resection. Secondary outcome measures included the duration of the TCRM, the fluid deficit recorded at TCRM, the resolution of symptoms post-operatively and the number of subsequent fibroid related operations. Forty-seven women were randomized to GnRH or placebo. On the basis of intention-to-treat analysis, there was no significant difference in the number of complete fibroid resections between women who received GnRH analogues [14/24, 58.3% (95% CI 38.6–78.1)] and those who received placebo [16/23, 69.6% (50.8–88.4)] (RR 0.84, 95% CI 0.54–1.29; P = 0.43). Similarly there was no significant difference between the groups in any of the secondary outcome measures. Our study does not support routine administration of GnRH analogues before transcervical resection of fibroid as we did not identify any benefit in such treatment. Controlled-trials.com: ISRCTN06560767.